Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAB (BIT-322) in activated human peripheral T cells

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3797-3804

  Dumont, Céline ^a   Déas, Olivier ^a   Mollereau, Bertrand ^a   Hebib, Chafika ^a   Giovino Barry, Valérie ^c   Bernard, Alain ^b   Hirsch, François ^a   Charpentier, Bernard ^a   Senik, Anna ^a,d  

^a CNRS   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c BioTransplant Inc   (United States)

^d UPR 420   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BTI 322; CD16 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G2B; INTERLEUKIN 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 2; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MIXED LYMPHOCYTE CULTURE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD2; APOPTOSIS; FEMALE; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; RATS; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 2642678473     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Dustin, M. L., M. E. Sanders, S. Shaw, and T. A. Springer. 1987. Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion. J. Exp. Med. 165:677.
2. Hahn, W. C., E. Menu, A. L. M. Bothwell, P. J. Sims, and B. E. Bierer. 1992. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 256:1805.
3. Deckert, M., J. Kubar, D. Zoccola, G. Bernard-Pormier, P. Angelisova, V. Horejsi, and A. Bernard. 1992. CD59 molecule: a second ligand for CD2 in T cell adhesion. Eur. J. Immunol. 22:2943.
4. Kato, K., M. Koyanagi, H. Okada, T. Takanashi, Y. W. Wong, A. F. Williams, K. Okumura, and H. Yagita. 1992. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J. Exp. Med. 176:1241.
5. Moingeon, P., H. C. Chang, B. P. Wallner, C. Stebbins, A. Z. Frey, and E. L. Reinherz. 1989. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature 339:312.
6. Vollger, L. W., D. T. Tuck, T. A. Springer, B. F. Haynes, and K. H. Singer. 1987. Thymocyte binding to human thymic epithelial cells is inhibited by monoclonal antibodies to CD2 and LFA-3 antigens. J. Immunol. 138:358.
7. Chang, H., P. Moingeon, R. Pederson, J. Lucich, C. Stebbin, and E. L. Reinherz. 1990. Involvement of the PPPGHR motif in T cell activation via CD2. J. Exp. Med. 172:351.
8. lck binds to proline-rich sequence in the cytoplasmic domaine of CD2 J. Exp. Med. 183:169.
9. fyn. Eur. J. Immunol. 23:2196.
10. Bell, G. M., J. B. Bolen, and J. B. Imboden. 1992. Association of Src-like protein tyrosine kinases with the CD2 cell surface molecule in rat T lymphocytes and natural killer cells. Mol. Cell. Biol. 12:5548.
11. lck is increased in human T cells activated via CD2. Eur. J. Immunol. 21:1967.
12. Samelson, L. E., M. C. Fletcher, J. A. Ledbetter, and C. H. June. 1990. Activation of tyrosine phosphorylation in human T cells via the CD2 pathway. Regulation by the CD45 tyrosine phosphatase. J. Immunol. 145:2448.
13. Hubert, P., P. Debré, L. Boumsell, and G. Bismuth. 1993. Tyrosine phosphorylation and association with phospholipase Cγ-1 of the GAP-associated 62-kD protein after CD2 stimulation of Jurkat T cells. J. Exp. Med. 178:1587.
14. Pantaleo, G., D. Olive, A. Poggi, W. J. Kozumbo, L. Moretta, and A. Moretta 1987. Transmembrane signalling via the T11-dependent pathway of human T cell activation: evidence for the involvement of 1,2-diaglycerol and inositol phosphates. Eur. J. Immunol. 17:55.
15. Meuer, S. C., R. E. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. L. Hodgdon, J. F. Potentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T-cell activation: a functional role for the 50 kD T11 sheep erythrocyte receptor protein. Cell 36:897.
16. Bierer, B. E., and S. J. Burakoff. 1991. T cell receptors: adhesion and signalling. Adv. Cancer Res. 56:49.
17. Moingeon, P. E., J. L. Lucich, C. C. Stebbins, M. A. Recny, B. P. Wallner, S. Koyasu, and E. L. Reinherz. 1991. Complementary roles of CD2 and LFA-1 adhesion pathways during T cell activation. Eur. J. Immunol. 21:601.
18. Yang, S. Y., S. Chouaib, and B. Dupont. 1986. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinant. J. Immunol. 37:1097.
19. Bierer, B., A. Peterson, J. C. Gorga, S. H. Herrmann, and J. S. Burakoff. 1988. Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J. Exp. Med. 168:145.
20. Siciliano, R. F., J. C. Pratt, R. E. Schmidt, J. Ritz, and L. E. Reinherz. 1985. Activation of cytolytic T lymphocytes and natural killer function through the T11 sheep erythrocyte binding protein. Nature 317:428.
21. Palacios, R., and O. Martinez-Maza. 1982. Is the E receptor on human T lymphocytes a "negative signal receptor"? J. Immunol. 129:1591.
22. Ohno, H., H. Nakamura, H. Yagita, K. Okumura, M. Taniguchi, and T. Saito. 1991. Induction of negative signal through CD2 during antigen-specific T cell activation. J. Immunol. 147:2100.
23. Miller, G. T., P. S. Hochman, W. Meier, R. Tizard, S. A. Bixler, M. D. Rosa, and B. P. Wallner. 1993. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. J. Exp. Med. 178:211.
24. Gückel, B., C. Berek, M. Lutz, P. Altevogt, V. Schirrmacher, and B. A. Kyewski. 1991. Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J. Exp. Med. 174-957.
25. Chavin, K. D., H. T. Lau, and J. S. Bromberg. 1992. Prolongation of allograft and xenograft survival by anti-CD2 monoclonal antibodies. Transplantation 54:286.
26. Hirahara, H., M. Tsuchida, T. Watanabe, M. Haga, Y. Matsumoto, T. Abo and S. Eguchi. 1995. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2. Transplantation 59:85.
27. Qin, L., K. D. Chavin, J. Lin, H. Yagita, and J. S. Bromberg. 1994. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J. Exp. Med. 179:341.
28. Krieger, N. R., D. Most, J. S. Bromberg, B. Holm, P. Huie, R. K. Sibley, D. C. Dafoe, and E. J. Alfrey. 1996. Coexistence of TH1- and TH2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance. Transplantation 62: 1285.
29. 1 fusion protein prolongs primate cardiac allograft survival. Transplantation 61:356.
30. + T cells is induced by some combinations of anti-CD2 mAb. J. Immunol. 151:3547.
31. Wesselborg, S., U. Prüfer, M. Wild, B. Schraven, S. C. Meuer, and D. Kabelitz. 1993. Triggering via the alternative CD2 pathway induces apoptosis in activated human lymphocytes. Eur. J. Immunol. 23:2707.
32. Rouleau, M., B. Mollereau, A. Bernard, D. Metivier, M. A. Rosenthal-Allieri, B. Charpentier, and A. Senik. 1994. Mitogenic CD2 monoclonal antibody pairs predispose peripheral T cells to undergo apoptosis upon interaction with a third CD2 monoclonal antibody. J. Immunol. 152:4861.
33. Mollereau, B., M. Deckert, O. Déas, F. Rieux-Laucat, F. Hirsch, A. Bernard, A. Fischer, D. H. Lynch, B. Charpentier, F. Le Deist, and A. Senik. 1996. CD2-induced apoptosis in activated human peripheral T cells. A Fas-independent pathway that requires early protein tyrosine phosphorylation. J. Immunol. 56:3184.
34. Xu, H., A. M. Ravoet, D. Latinne, J. Ninanne, M. De Bruyère, G. Sokal, and H. Bazin. 1990. Rat monoclonal antibodies specific for human T lymphocytes. In Rat Hybridomas and Rat Monoclonal Antibodies, H. Bazin, ed. CRC Press, Boca Raton, FL, p. 309.
35. Latinne, D., B. De La Parra, Y. Nizet, A. Cornet, V. Giovino-Barry, R. L. Monroy, M. E. White-Scharf, and H. Bazin. 1996. an anti-CD2 monoclonal antibody induces immunosuppression and hyporesponsiveness of CD2 positive human T cells in vitro. Int. Immunol. 8:7.
36. Shad, V., J. L. Greenstein, V. Giovino-Barry, A. LeGuern, A. Matejic, T. Glaser, M. Dickerson, Y. Xu, H. Bazin, D. Latinne, R. Monroy, and M. E. White-Scharf. 1996. An anti-CD2 monoclonal antibody elicits alloantigen-specific hyporesponsiveness. Transplant. Proc. 28:2051.
37. Ben Aribia, M. H., N. Moiré, D. Métivier, C. Vaquero, O. Lantz, D. Olive, B. Charpentier, and A. Senik. 1989. Il-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal. J. Immunol. 142:490.
38. + peripheral blood lymphocytes. J. Exp. Med. 179:857.
39. Olive, D., M. Ragueneau, C. Cerdan, P. Dubreuil, M. Lopez, and C. Mawas. 1986. Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and anti-T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate. Eur. J. Immunol. 16:1063.
40. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
41. Bernard, A., E. Brottier, E. Georget, V. Lepage, and L. Boumsell. 1984. The epitopic dissection of CD2 defined molecule: relationship of the Second Workshop antibodies in terms of reactivities with lymphocytes, rosettes blocking properties induction of positive modulation of the molecule, and triggering T cell activation. In Proceedings of the Second International Workshop on Human Differentiation Antigens. E. L. Reinherz, B. F. Haynes, L. M. Nadler, and I. D. Berstein, eds. Springer-Verlag, New York, pp. 53-66.
42. 1 epitopes. J. Immunol. 135:1624.
43. O'Flynn, K., A. M. Krensky, P. C. L. Beverley, S. J. Burakoff, and D. C. Linch. 1985. Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor. Nature 313:686.
44. Tiefenthaler, G., and T. Hunig. 1989. The role of CD2/LFA-3 interaction in antigen- and mitogen-induced activation of human T cells. Int. Immunol. 1989: 1:169.
45. Kanellopoulos, J. M., S. De Petris, G. Leca, and M. J. Crumpton. 1985. the mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes. Eur. J. Immunol. 15:479.
46. Radvanyi L. G., Y. Shi, H. Vaziri, A. Sharma, R. Dhala, G. B. Mills, and R. G. Mills. 1996. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J. Immunol. 156:1788.
47. Mollereau, B., D. Blanchard, O. Déas, C. Dumont, D. Métivier, A. Bernard, B. Charpentier, A. Vazquez, and A. Senik. 1997. Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes: T cells manifesting proliferative unresponsiveness are preferentially susceptible to CD95-mediated apoptosis. J. Immunol. 159:2668.
48. Boussiotis, V. A., G. J. Freeman, J. D. Griffin, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1994. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J. Exp. Med. 180:1665.
49. Li, J. L., A. Smolyar, R. Sunder-Plassmann, and E. L. Reinherz. 1996. Ligand-induced conformational change within the CD2 ectodomain accompanies receptor clustering: implication for molecular lattice formation. J. Mol. Biol. 263:209.
50. Brown, M. H., D. A. Cantrell, G. Brattsand, M. J. Crumpton, and M. Gullberg. 1989. The CD2 antigen associates with the T-cell antigen receptor CD3 antigen complex on the surface of human T lymphocytes. Nature 339:551.
51. Schraven, B., Y. Samstag, P. Altevogt, and S. C. Meuer. 1990. Association of CD2 and CD45 on human T lymphocytes. Nature 345:71.
52. Ley, S. C., A. A. Davies, B. Druker, and M. J. Crumpton. 1991. The T cell receptor/CD3 complex and CD2 stimulate the tyrosine phosphorylation of indistinguishable patterns of polypeptides in the human T leukemic cell line Jurkat. Eur. J. Immunol. 21:2203.
53. Weissman, A. M., P. Ross, E. T. Luong, P. Garcia-Morales, M. L. Jelashich, W. E. Biddison, R. D. Klausner, and L. E. Samelson. 1988. Tyrosine phosphorylation of the human T cell antigen receptor zeta-chain: activation via CD3 but not CD2. J. Immunol. 141:3532.
54. Hubert, P., V. Lang, P. Debré, and G. Bismuth. 1996. Tyrosine phosphorylation and recruitment of ZAP-70 to the CD3-TCR complex are defective after CD2 stimulation. J. Immunol. 157:4322.
55. lck. Eur. J. Immunol. 22:2915.
56. Ortaldo, J. R., A. T. Mason, and J. J. O'Shea. 1995. Receptor-induced death in human natural killer cells: involvement of CD16. J. Exp. Med. 181:339.
57. + cells mobilized by granulocyte colony-stimulating factor. Br. J. Hematol. 92:788.
58. - subset from PBL and NK cells in long-term IL-2 cultures enhanced by prothymosin-alpha. Immunopharmacology 29:215.
59. Woodword, J. E., L. Qin, K. D. Chavin, J. Lin, K. Tono, Y. Ding, P. S. Lindsley, J. S. Bromberg, and P. Baliga. 1996. Blockade of multiple costimulatory receptors induces hyporesponsiveness. Transplantation 62:1011.
60. Lin, J., R. W. Yon, K. D. Chavin, L. Qin, J. Woodward, Y. Ding, H. Yagita, and J. S. Bromberg. 1995. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2. Transplantation 59:1162.
61. Böhmig, G. A., J. Kovarik, W. Holter, E. Pohanka, and G. J. Zlabinger. 1994. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA3 and LFA-1/IAM-1 in vitro. J. Immunol. 152:3720.
62. Squifflet, J. P., T. Besse, J. Malaise, M. Mourad, C. Delcorde, J. A. Hope, and Y. Pirson. 1997. BTI-322 for induction therapy after renal transplantation: a randomized study. Transplant. Proc. 29:317.